Executive record

Emil D. Kakkis, M.D., Ph.D.

President, Chief Executive Officer and Director at Ultragenyx Pharmaceutical Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:emil-d-kakkis-m-d-ph-dVersion: public-0As of: 2026-09-29

Not yet claimed8 published Claims3 sources
  • Executive
  • Director

Key Claims

Biography

Biographical information for Dr. Kakkis is set forth under Proposal No. 1 (Election of Class I Directors). He serves as President and Chief Executive Officer and Director of Ultragenyx Pharmaceutical Inc.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Current · dates not publishedPresident and Chief Executive Officer · Ultragenyx Pharmaceutical Inc.
  2. 2026 to end not publishedExecutive title: President and Chief Executive Officer, Director · Organization not publishedRARE DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. RARE DEF 14A executive officers

    sec filing · Source published: Mar 27, 2026 · Retrieved: May 5, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at Ultragenyx Pharmaceutical Inc. · Claim reviewed: May 5, 2026
    • Executive title: Executive title: President and Chief Executive Officer, Director · Claim reviewed: May 5, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026

  2. Open source

    sec def 14a · Source published: Mar 27, 2026 · Retrieved: Sep 12, 2026

    Supports 2 claims
    • Professional Role: President, Chief Executive Officer and Director at Ultragenyx Pharmaceutical Inc. · Claim reviewed: Sep 12, 2026
    • Professional Role: President and Chief Executive Officer at Ultragenyx Pharmaceutical Inc. · Claim reviewed: Sep 12, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Ultragenyx Pharmaceutical Inc. · Claim reviewed: Sep 12, 2026